VENOUS ACCESS VIA A PERIPHERALLY IMPLANTED DEVICE: A PRELIMINARY TRIAL (MEETING ABSTRACT)

Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

VENOUS ACCESS VIA A PERIPHERALLY IMPLANTED DEVICE: A PRELIMINARY TRIAL (MEETING ABSTRACT)

Proc Annu Meet Am Soc Clin Oncol; 10:A1153 1991. Unique Identifier : AIDSLINE ICDB/91672490
Hoisington S; Remick S; MacDowell R; Hilstro J; Ramnes C; Izquierdo R; Harper G; Ruckdeschel J; Albany Medical Coll., Albany NY 12208

Abstract: A peripherally implanted venous access device (Ultra Low Profile Implantable Access System, Pharmacia Deltec Inc. [PDI], St Paul, MN) was evaluated in 11 patients (pts), 9 with cancer and 2 with AIDS. All had the device placed surgically (median duration: 1 hr, range 0.75-2.5) in either the brachial or basilic vein via cutdown or percutaneous passage, with the access portal on the anterior aspect of the forearm. The catheter tip was positioned in the superior vena cava with the assistance of the Cath-Finder Catheter Tracking System (PDI). The median follow-up was 80 days (range 27-191). The devices were accessed on 129 occasions using a variety of noncoring needles (PDI 20 g/22 g, Grippper 20 g, Marquis 22 g, and others). Reasons for access included chemotherapy (63 instances), hydration (24), antibiotics (13), transfusion (5), and aspiration/flushing (24). Local tenderness, swelling or edema was noted on 46 of 129 (36%) device accesses. Numbness of the forearm occurred in 2 pts following the operation, but resolved. On 14 of 129 (11%) occasions there were 12 instances of difficult aspiration and 2 of needle placement problems in the portal due to overlying swelling. On 2 occasions, the device became occluded; they were relieved with urokinase and infiltrated on 4 occasions. The device was effective and well tolerated, and may be recommended for pts with extensive chest wall tumors and HIV infection to facilitate access.

Keywords: Acquired Immunodeficiency Syndrome/*DRUG THERAPY Catheterization, Peripheral/*INSTRUMENTATION *Catheters, Indwelling Forearm/BLOOD SUPPLY Human Neoplasms/*DRUG THERAPY Vena Cava, Superior ABSTRACT
911030
M91A1123

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .